IRMD

IRADIMED CORP

IRMD·46266A109·US·Common Stock·Healthcare - Medical Devices-13D/G

IRMD (IRADIMED CORP) is held by 117 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($93.2M), RENAISSANCE TECHNOLOGIES LLC ($42.4M), VANGUARD CAPITAL MANAGEMENT LLC ($34.5M). Net institutional sentiment: Mixed.

117
Holders
(11 Elite)
$517.4M
Total Value
60% (116)
Consensus
70 buying - 46 selling
13F: Insider & Congress:
IRMDSmart Money Verdict
View all
Held by 117 funds
11 elite
Who's Trading
InsiderSFScharen-Guivel Hilda FrederiqueSell $168KJun 4, 2026
InsiderSFScharen-Guivel Hilda FrederiqueSell $117KJun 4, 2026
InsiderSESusi Roger E.Sell $35KJun 1, 2026
InsiderSESusi Roger E.Sell $70KJun 1, 2026
InsiderSESusi Roger E.Sell $37KJun 1, 2026
InsiderSESusi Roger E.Sell $85KJun 1, 2026
InsiderSESusi Roger E.Sell $199KMay 27, 2026
InsiderSESusi Roger E.Sell $31KMay 27, 2026
ActivistRERoger E. Susi34.8%May 14, 2026
ActivistNTNine Ten Capital Management3.4%Feb 10, 2026
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Decreased
967,787(-3.4%)$93.2M0.0%+76.34%
0
Decreased
440,712(-3.4%)$42.4M0.1%+348.73%
0
New
358,620$34.5M0.0%-6.80%
40
Increased
349,316(+4.8%)$33.6M0.1%-0.89%
30
Increased
286,563(+9.4%)$27.6M0.0%+124.76%
31
Increased
226,146(+4.2%)$21.8M0.0%+126.52%
30
Increased
204,528(+6.0%)$19.7M0.0%+85.80%
30
Decreased
197,945(-3.5%)$19.1M0.0%+46.33%
0
Increased
165,669(+155.2%)$15.9M0.0%+9.97%
45
Increased
149,839(+11.2%)$14.4M0.0%+64.95%
31
Decreased
123,636(-6.4%)$11.9M0.0%+173.53%
0
New
122,425$11.8M0.0%-6.80%
39
Decreased
99,498(-8.9%)$9.6M0.0%+188.74%
0
Increased
86,129(+268.7%)$8.3M0.0%+7.95%
44
Increased
83,449(+36.9%)$8M0.0%+43.74%
36
Decreased
79,877(-6.6%)$7.7M0.0%+144.75%
0
Increased
75,460(+19.0%)$7.3M0.0%+78.33%
32
Increased
74,304(+17.2%)$7.2M0.0%+16.17%
32
Increased
71,836(+130.4%)$6.9M0.0%-0.60%
44
Increased
67,069(+0.5%)$6.5M0.0%+9.18%
27

Showing 1-20 of 124

1 / 7

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used